Clinical Trial Update: Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn [Phase 3]

View source ↗

Summary

Phase 3 study evaluating diclofenac sodium 0.1% gel for UV-induced painful sunburn has completed, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sunburn

Drugs mentioned

• Diclofenac Sodium Gel 0.1% (diclofenac)

Snippet

Sponsor: Novartis | Conditions: Sunburn | Phase 3 | Status: COMPLETED